Alira Health

Regulatory: MedTech

FDA U.S. Agent for Non-U.S. Companies

Providing guidance and expertise as liaisons

As a global company headquartered in the U.S., we understand the challenges of working with FDA regulatory as a non-U.S. organization. Our team of U.S.-based project managers have years of experience working with the FDA, and regularly guide our clients through the process as an FDA liaison.

Our liaisons serve in active negotiation with regulatory bodies, providing expertise and guidance for our clients on:
  • FDA establishment registration and device listing
  • FDA U.S. agent for foreign establishments
  • EU authorized representative

Why choose Alira Health?

With Alira Health as your partner, you will benefit from:

  • Innovation support, optimizing product development success every step of the way
  • Integrated and collaborative teams experience
  • Lifecycle approach

Related news

News September 1, 2026
Alira Health Advises Mindful Capital Partners on the Sale of Portfolio Company Sidam S.r.l. to Plastiflex Group
Alira Health is pleased to have acted as Vendor Due Diligence Advisor to Mindful Capital Partners, an independent cross-border private equity firm focused on mid-market companies across(...)
MedTech
Reports and White Papers September 1, 2026
Global Medtech Contract Development and Manufacturing Market H1 2026 M&A Update
Learn about the H1 2026 M&A trends in the medtech CDMO market including deal activity, geographic distribution of transactions, and target end-markets.
CDMO MedTech
Articles August 19, 2026
How to Develop Global Clinical Evidence Strategies for Regulatory Success in Medtech
Discover how a strategically planned clinical evidence generation strategy can support global device approval, maximize evidence value, and prepare for international expansion.
MedTech Regulatory
Events July 24, 2026
MedTech World Asia 2026
Meet our team at MedTech World Asia 2026 and learn how our integrated model can support your international expansion and drive commercial success.
MedTech
Articles July 24, 2026
How Pharma and Medtech Convergence Is Changing DDS Partner Selection in 2026
Learn how pharma and medtech convergence is reshaping drug delivery system partner selection, from combination products and regulatory readiness to integrated execution.
Drug Delivery MedTech Pharma
Articles July 21, 2026
Preparing Rare Disease Manufacturers for JCA: The Role of Early Stakeholder Engagement
Discover how stakeholder engagement helps rare disease manufacturers prepare for JCA and how to apply stakeholder management best practices in the JCA context.
Healthcare Technology Rare Disease Regulatory
Case Studies June 16, 2026
Infection Control and Prevention Company Defines Winning US Market Entry Strategy
Discover how an infection prevention company defined a successful US market entry strategy amid regulatory uncertainty for novel wound care disinfectant products.
Infection Prevention Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.